These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 22412354)
1. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354 [TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598 [TBL] [Abstract][Full Text] [Related]
3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB; Porterfield D Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340 [TBL] [Abstract][Full Text] [Related]
4. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users]. Veljković M; Veljković S Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095 [TBL] [Abstract][Full Text] [Related]
5. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use? Khoo SK Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357 [TBL] [Abstract][Full Text] [Related]
6. [Use of oral contraceptives and risk of cancer, a cohort study]. Kumle M; Alsaker E; Lund E Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980 [TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and gynecologic cancer: an update for the 1990s. Kaunitz AM Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442 [TBL] [Abstract][Full Text] [Related]
8. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study. Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769 [TBL] [Abstract][Full Text] [Related]
9. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives. Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM Aust N Z J Public Health; 2015 Oct; 39(5):441-5. PubMed ID: 26437729 [TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and reproductive system cancer. Deligeoroglou E; Michailidis E; Creatsas G Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia. Gwinn ML J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773 [TBL] [Abstract][Full Text] [Related]
12. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis. Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819 [TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. La Vecchia C; Decarli A; Fasoli M; Franceschi S; Gentile A; Negri E; Parazzini F; Tognoni G Br J Cancer; 1986 Aug; 54(2):311-7. PubMed ID: 3741766 [TBL] [Abstract][Full Text] [Related]
14. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. dos Santos Silva I; Swerdlow AJ Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237 [TBL] [Abstract][Full Text] [Related]
15. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. Michels KA; Pfeiffer RM; Brinton LA; Trabert B JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467 [TBL] [Abstract][Full Text] [Related]
16. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers. Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study. Vessey M; Yeates D Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961 [TBL] [Abstract][Full Text] [Related]
19. Oral contraception and cancer of the female reproductive system. Woods KL J Clin Hosp Pharm; 1985 Jun; 10(2):123-35. PubMed ID: 3894428 [TBL] [Abstract][Full Text] [Related]
20. Sexual, reproductive and contraceptive risk factors for carcinoma-in-situ of the uterine cervix in Sydney. Brock KE; Berry G; Brinton LA; Kerr C; MacLennan R; Mock PA; Shearman RP Med J Aust; 1989 Feb; 150(3):125-30. PubMed ID: 2716580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]